Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Banneker Partners is an active private equity and growth capital firm specializing in investments in enterprise software, SaaS, Internet, and technology businesses. It does not operate as a biotech or healthcare company.
The firm partners with management teams to drive organic growth and strategic M&A for lower-middle market software companies. Recent investments include Arkieva (supply chain SaaS), XBE/BCMI merger (construction logistics), Remsoft (forest intelligence), among others.
As of June 2025, the firm manages over $2 billion in assets across multiple funds.
There are no clinical results or drug development programs associated with this entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Banneker Partners.